FDA Inspection 1254228 - 3D LifePrints USA Inc. D.B.A. Insight Surgery - November 15, 2024

FDA Inspection 1254228 for 3D LifePrints USA Inc. D.B.A. Insight Surgery on November 15, 2024. Classification: No Action Indicated (NAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1254228 for 3D LifePrints USA Inc. D.B.A. Insight Surgery on November 15, 2024. Classification: No Action Indicated (NAI).

Violation Codes

21 CFR 820.30(i)

21 CFR 820.30(j)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

3D LifePrints USA Inc. D.B.A. Insight Surgery

Inspection Date

November 15, 2024

Product Type

Devices

Office

Center for Devices and Radiological Health

ID: ff7a5712-4429-4bd2-b0a7-4e707b898457

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox